Question · Q1 2026
Tom Hayes asked for a reminder about Enerpac Tool Group's Cortland business, which is part of the "other" segment, and the factors driving its continued strong growth.
Answer
Paul Sternlieb, CEO of Enerpac Tool Group, expressed satisfaction with Cortland Biomedical, describing it as a roughly $20 million annual revenue business that is high-growth, high-margin, and operates relatively independently. He explained that it designs and manufactures custom biomedical textile fibers for specific medical devices for OEM customers, making it a long-cycle, sticky business with strong growth opportunities and a robust funnel.
Ask follow-up questions
Fintool can predict
EPAC's earnings beat/miss a week before the call